IXICO plc (LON:IXI – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 11.51 and traded as low as GBX 8.82. IXICO shares last traded at GBX 8.82, with a volume of 11,405 shares.
IXICO Stock Down 12.7%
The company has a quick ratio of 4.90, a current ratio of 2.85 and a debt-to-equity ratio of 3.32. The company’s fifty day moving average price is GBX 10.89 and its 200-day moving average price is GBX 11.47. The stock has a market capitalization of £7.18 million, a PE ratio of -4.19, a price-to-earnings-growth ratio of -0.38 and a beta of 0.86.
IXICO (LON:IXI – Get Free Report) last announced its quarterly earnings data on Tuesday, December 9th. The company reported GBX (1.85) earnings per share (EPS) for the quarter. IXICO had a negative net margin of 31.10% and a negative return on equity of 19.14%. Analysts forecast that IXICO plc will post -289.3584879 earnings per share for the current year.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Featured Articles
- Five stocks we like better than IXICO
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
